Form 8-K - Current report:
SEC Accession No. 0001193125-12-064391
Filing Date
2012-02-16
Accepted
2012-02-16 08:12:46
Documents
5
Period of Report
2012-02-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d302169d8k.htm 8-K 26221
2 LETTER AGREEMENT WITH DR. STEVEN B. KETCHUM d302169dex101.htm EX-10.1 46316
3 PRESS RELEASE d302169dex991.htm EX-99.1 14545
4 GRAPHIC g302169ex99_1pg01.jpg GRAPHIC 15470
5 GRAPHIC g302169logo.jpg GRAPHIC 24034
  Complete submission text file 0001193125-12-064391.txt   143336
Mailing Address FIRST FLOOR, BLOCK 3, THE OVAL, SHELBOURNE ROAD, BALLSBRIDGE DUBLIN L2 00000
Business Address FIRST FLOOR, BLOCK 3, THE OVAL, SHELBOURNE ROAD, BALLSBRIDGE DUBLIN L2 00000 353 1 6699 020
AMARIN CORP PLC\UK (Filer) CIK: 0000897448 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-176897 | Film No.: 12617720
SIC: 2834 Pharmaceutical Preparations